IBNSINA PHARMA EGX:ISPH:
IBNSINA PHARMA Q1 CONSOL NET PROFIT ATTRIBUTABLE EGP 181.9 MILLION
IBNSINA PHARMA Q1 CONSOL NET SALES EGP 17.04 BILLION
IBNSINA PHARMA EGX:ISPH:
IBNSINA PHARMA Q1 CONSOL NET PROFIT ATTRIBUTABLE EGP 181.9 MILLION
IBNSINA PHARMA Q1 CONSOL NET SALES EGP 17.04 BILLION